Skip to main content
OpenTrials
Completed

NCT Number: NCT01760512

Clinical and Health Economic Impact of Robot-assisted Surgery vs Conventional Laparoscopy : the Case of Gastric Bypass

The purpose of this study is to gather clinical and economic evidence on the use of robotics for bariatric surgery (gastric bypass).

This monocentric, randomized, single blind, controlled study will evaluate post-operative pain, quality of life and appetite, post-operative complication incidence. It will also provide information on direct and indirect costs of surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Service de Chirurgie Digestive et Endocrinienne

Strasbourg, 67 000, France

About this study

Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery (Gastric Bypass): a prospective, single-blind, randomized, non-inferiority, and controlled study The main evaluation criterion is 24h post-operative pain assessed using visual analog scale (VAS). Secondary criteria included for clinical assessment: post 24h pain, excess weight loss, quality of life, appetite, complications, conversion rate; and for health-economics assessment : duration of surgical steps, length of stay, return to normal activity and their conversion to cost, consumables, estimation of indirect costs and benefits (e.g., robotics perception, publication).

In this study, main inclusion criteria include major obesity (IMC ≥ 35) with co-morbidities or morbid obesity (IMC ≥ 40), scheduled gastric bypass surgery Main contraindications are previous bariatric surgery and previous major abdominal surgeries To test robotic-assisted surgery non-inferiority on VAS pain score 24h post-surgery, a total of 128 patients (64 per arm) is to be included (alpha 2,5%; power 90%; drop-out rate: 5%).

The study will include 12 months of follow-up post-surgery for each patient. The total study duration is 2 years and 3 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient presenting with major obesity (BMI ≥ 35) with co-morbidities or morbid obesity (BMI ≥ 40)according to French HAS (Haute Autorité de Santé) and CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salariés)criteria for whom gastric bypass is scheduled
  • Male or female between 18 and 65 years old
  • Patient registered with the French Social Security
  • Patient having provided a written informed consent prior to enrolment
  • Patient accepting to attend follow-up visits as required by study protocol

Exclusion criteria

  • Patient with a BMI ≥ 60
  • Patient with a contraindication for laparoscopic gastric bypass with or without robotic assistance
  • Patient having had prior bariatric surgery
  • Patient having had prior major abdominal surgery
  • Patient in exclusion period of another clinical study
  • Patient pregnant or breastfeeding
  • Patient without sufficient knowledge of french language or unable to receive or understand study related information and answer to questionnaires
  • Patient with no or limited legal capacity

Treatment and study plan

Gastric bypass

Procedure

Gastric bypass

Primary outcomes

  1. 24h postoperative pain

    Time frame: 24h

    Pain assessment 24h post surgery (visual analog scale)

Secondary outcomes

  1. Evaluation of post-operative pain

    Time frame: 24h, 8 days, 1, 3, 6 and 12 months

    Evaluation of post-operative pain (beyond 24h post-operative) using VAS

  2. Evaluation of quality of life (BAROS and GIQLI)

    Time frame: At 1, 3, 6 and 12 months

    Evaluation of quality of life using BAROS and GIQLI questionaires

  3. Evaluation of appetite level

    Time frame: At 8 days, 1, 3, 6 and 12 months

    Evaluation of appetite level using VAS

  4. Percentage of excess weight loss

    Time frame: At 8 days, 1, 3, 6 and 12 months

    Measure of excess weight loss - % from baseline

  5. Conversion rate to conventional laparoscopy

    Time frame: During the procedure (Day 0)

    Conversion rate to conventional laparoscopy (only applicable to robot-assisted surgery arm)

  6. Nature of per-operative complications

    Time frame: During the procedure (Day 0)

    Nature of per-operative complications

  7. Nature of post-operative complications

    Time frame: Following the procedure (Day 0) up to 12 months

    Nature of post-operative complications

  8. Evaluation of operative times

    Time frame: During the procedure (Day 0)

    Evaluation of key steps of gastric bypass surgery, OR occupation time

  9. Evaluation of direct costs

    Time frame: During the procedure (day 0) and up to 12 months

    Direct costs include material used, OR occupation time, length of stay, return to normal activity

  10. Evaluation of indirect costs

    Time frame: Up to 12 months

    Combination of number of patients having surgery, perception of robot-assisted surgery by both personnel and patients, publications, and communications

Sponsors and collaborators

Lead sponsor

IHU Strasbourg

Other

Registry information

Official study title

Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jan 4, 2013
Registry last updated
Dec 10, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.